Assembly of the Mycobacterial Wall M Jankute, JAG Cox, J Harrison, GS Besra Annual Review of Microbiology 69, 2015 | 441 | 2015 |
Dissecting the antimicrobial composition of honey VC Nolan, J Harrison, JAG Cox Antibiotics 8 (4), 251, 2019 | 214 | 2019 |
Identification of novel imidazo [1, 2-a] pyridine inhibitors targeting M. tuberculosis QcrB KA Abrahams, JAG Cox, VL Spivey, NJ Loman, MJ Pallen, ... PloS one 7 (12), e52951, 2012 | 206 | 2012 |
Mycobacterium abscessus: Environmental Bacterium Turned Clinical Nightmare RC Lopeman, J Harrison, M Desai, JAG Cox Microorganisms 7 (3), 90, 2019 | 152 | 2019 |
Identification of KasA as the cellular target of an anti-tubercular scaffold KA Abrahams, C Chung, S Ghidelli-Disse, J Rullas, MJ Rebollo-López, ... Nature communications 7 (1), 12581, 2016 | 99 | 2016 |
THPP target assignment reveals EchA6 as an essential fatty acid shuttle in mycobacteria JAG Cox, KA Abrahams, C Alemparte, S Ghidelli-Disse, J Rullas, ... Nature Microbiology, doi:10.1038/nmicrobiol.2015.6, 2016 | 72 | 2016 |
Inhibiting mycobacterial tryptophan synthase by targeting the inter-subunit interface KA Abrahams, JAG Cox, K Fütterer, J Rullas, F Ortega-Muro, NJ Loman, ... Scientific Reports 7 (1), 9430, 2017 | 61 | 2017 |
Clinical significance of manuka and medical-grade honey for antibiotic-resistant infections: a systematic review VC Nolan, J Harrison, JEE Wright, JAG Cox Antibiotics 9 (11), 766, 2020 | 60 | 2020 |
Mycobacterial Dihydrofolate Reductase Inhibitors Identified Using Chemogenomic Methods and G Mugumbate, KA Abrahams, JAG Cox, G Papadatos, G van Westen, ... journal.pone.0121492 10, (3): e0121492. doi:10.1371, 2015 | 57* | 2015 |
Modelling a silent epidemic: a review of the in vitro models of latent tuberculosis SER Gibson, J Harrison, JAG Cox Pathogens 7 (4), 88, 2018 | 55 | 2018 |
Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus RC Lopeman, J Harrison, DL Rathbone, M Desai, PA Lambert, JAG Cox Scientific reports 10 (1), 928, 2020 | 48 | 2020 |
Biochemical and structural characterization of mycobacterial aspartyl-tRNA synthetase AspS, a promising TB drug target SS Gurcha, V Usha, JAG Cox, K Fütterer, KA Abrahams, A Bhatt, ... PloS one 9 (11), e113568, 2014 | 42 | 2014 |
Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen JAG Cox, G Mugumbate, LVGD Peral, M Jankute, KA Abrahams, P Jervis, ... Scientific Reports 6 (38986), doi: 10.1038/srep38986, 2016 | 37 | 2016 |
Antimycobacterial drug discovery using Mycobacteria-infected amoebae identifies anti-infectives and new molecular targets V Trofimov, S Kicka, S Mucaria, N Hanna, F Ramon-Olayo, LVG Del Peral, ... Scientific reports 8 (1), 3939, 2018 | 31 | 2018 |
The ‘Antibiotic Apocalypse’–scaremongering or scientific reporting? JAG Cox, T Worthington Trends in microbiology 25 (3), 167-169, 2017 | 27 | 2017 |
Indole-containing arene-ruthenium complexes with broad spectrum activity against antibiotic-resistant bacteria VC Nolan, L Rafols, J Harrison, JJ Soldevila-Barreda, M Crosatti, ... Current research in microbial sciences 3, 100099, 2022 | 25 | 2022 |
Identification and validation of the mode of action of the chalcone anti-mycobacterial compounds B Anagani, J Singh, JP Bassin, GS Besra, C Benham, TRK Reddy, ... The Cell Surface 6, 100041, 2020 | 16 | 2020 |
The drugs don't work: evaluation of educational theatre to gauge and influence public opinion on antimicrobial resistance R Ahmed, A Bashir, JEP Brown, JAG Cox, AC Hilton, CE Hilton, ... Journal of Hospital Infection 104 (2), 193-197, 2020 | 16 | 2020 |
Dissecting the antimicrobial composition of honey. Antibiotics 8: 251 VC Nolan, J Harrison, JAG Cox Go to original source... Go to PubMed, 2019 | 16 | 2019 |
Microfluidics as a novel technique for tuberculosis: from diagnostics to drug discovery A Molloy, J Harrison, JS McGrath, Z Owen, C Smith, X Liu, X Li, JAG Cox Microorganisms 9 (11), 2330, 2021 | 14 | 2021 |